Paydirt
BD
Insider

Behrad Derakhshan

Chief Business Officer

Behrad Derakhshan (Chief Business Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Edgewise Therapeutics, Inc. (EWTX). The largest single filing was $108K of EWTX (2,475 sh × $43.70, as filed), executed Aug 12.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$108K
shares × price, as filed
Last traded
Aug 12
Filed Aug 14

Median ADV $64.2M across their filed names

Open performance
Volume by month
$300K$150K$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2025 · sells $300KAug 2026 · sells $108K
Buys $0 Sells $408K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
EWTX Edgewise Therapeutics, Inc. EWTX · 0 buys · 3 sells 3 filings
Recent filings
EWTXSALE Edgewise Therapeutics, Inc. View filing → $108K
2,475 sh × $43.70
Exec Aug 12
Filed Aug 14 · 4:53 PM ET
EWTXSALE Edgewise Therapeutics, Inc. View filing → $300K
10,000 sh × $30.03
Exec Feb 5 2025
Filed Feb 7 2025 · 5:30 PM ET
EWTXSALE Edgewise Therapeutics, Inc. View filing → $1.2M
42,068 sh × $29.03
Exec Sep 20 2024
Filed Sep 24 2024 · 5:30 PM ET